Tighe Reardon

JANX

Tighe Reardon serves as Acting Chief Financial Officer at Janux Therapeutics, Inc. (JANX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$15.69M

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$15.69M

Companies Traded

JANX

Active Period

Jun 2021 – Nov 2023

2 total trades

Most Recent

Buy JANX

Nov 15, 2023 · $4.99M

Tighe Reardon's Insider Trading at Janux Therapeutics, Inc. (JANX)

Buys

2 · $15.69M

Sells

0 · $0.00

Total Shares Bought

1,479,265

Total Shares Sold

JANX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 15, 2023	Buy	849,854	$5.87	$4.99M	849,854
Jun 16, 2021	Buy	629,411	$17.00	$10.70M	4,479,492

Related Insiders

Janeen Noel Doyle

officer: Chief Corp. & Bus. Dev. Ofcr

JANXSell · Jun 4, 2026

Maria Dobek

Vice President, Accounting

JANXSell · May 13, 2026

Thomas DiRaimondo

Chief Scientific Officer

JANXSell · Jan 2, 2026

David Alan Campbell

President and CEO

JANXSell · Jan 2, 2026

Zachariah McIver

Chief Medical Officer

JANXSell · Jan 2, 2026

Andrew Hollman Meyer

Chief Business Officer

JANXSell · Jan 2, 2026

Charles M. Winter

Chief Technical Officer

JANXSell · Jan 2, 2026

Explore More Insider Trading Data

JANX Insider Trading Activity

View all insider trades at Janux Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity